was read the article
array:24 [ "pii" => "S1579212918300892" "issn" => "15792129" "doi" => "10.1016/j.arbr.2018.03.001" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1805" "copyright" => "SEPAR" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:298" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1077 "formatos" => array:3 [ "EPUB" => 154 "HTML" => 599 "PDF" => 324 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289618300139" "issn" => "03002896" "doi" => "10.1016/j.arbres.2017.12.015" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1805" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:298" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2055 "formatos" => array:3 [ "EPUB" => 160 "HTML" => 1358 "PDF" => 537 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Comentarios a la normativa SEPAR de diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "298" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Comments on the SEPAR Guidelines for the Diagnosis and Treatment of Drug-Resistant Tuberculosis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José A. Caminero, Joan A. Caylá, José-María García-García, Francisco J. García-Pérez, Juan J. Palacios, Juan Ruiz-Manzano" "autores" => array:6 [ 0 => array:2 [ "nombre" => "José A." "apellidos" => "Caminero" ] 1 => array:2 [ "nombre" => "Joan A." "apellidos" => "Caylá" ] 2 => array:2 [ "nombre" => "José-María" "apellidos" => "García-García" ] 3 => array:2 [ "nombre" => "Francisco J." "apellidos" => "García-Pérez" ] 4 => array:2 [ "nombre" => "Juan J." "apellidos" => "Palacios" ] 5 => array:2 [ "nombre" => "Juan" "apellidos" => "Ruiz-Manzano" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212918300892" "doi" => "10.1016/j.arbr.2018.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300892?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289618300139?idApp=UINPBA00003Z" "url" => "/03002896/0000005400000005/v1_201805020858/S0300289618300139/v1_201805020858/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1579212918300843" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.09.018" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1764" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:298-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 942 "formatos" => array:3 [ "EPUB" => 142 "HTML" => 521 "PDF" => 279 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "GesEPOC Guidelines in the Elderly: Still a Long Way to Go" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "298" "paginaFinal" => "299" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guías GesEPOC en ancianos: todavía camino por recorrer" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nicolás Martínez-Velilla, Cristina Ibarrola Guillén, José Javier Celorrio Astiz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Nicolás" "apellidos" => "Martínez-Velilla" ] 1 => array:2 [ "nombre" => "Cristina Ibarrola" "apellidos" => "Guillén" ] 2 => array:2 [ "nombre" => "José Javier Celorrio" "apellidos" => "Astiz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289617304106" "doi" => "10.1016/j.arbres.2017.09.019" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289617304106?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300843?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300843/v1_201804290447/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1579212918300831" "issn" => "15792129" "doi" => "10.1016/j.arbr.2017.10.023" "estado" => "S300" "fechaPublicacion" => "2018-05-01" "aid" => "1763" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2018;54:297" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 998 "formatos" => array:3 [ "EPUB" => 131 "HTML" => 578 "PDF" => 289 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on the Treatment of Resistant Tuberculosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "297" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios al tratamiento de la tuberculosis con resistencia" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Francisco Pascual Pareja" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José Francisco" "apellidos" => "Pascual Pareja" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S030028961730409X" "doi" => "10.1016/j.arbres.2017.10.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028961730409X?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300831?idApp=UINPBA00003Z" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300831/v1_201804290447/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on the SEPAR Guidelines for the Diagnosis and Treatment of Drug-Resistant Tuberculosis" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "298" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "José A. Caminero, Joan A. Caylá, José-María García-García, Francisco J. García-Pérez, Juan J. Palacios, Juan Ruiz-Manzano" "autores" => array:6 [ 0 => array:4 [ "nombre" => "José A." "apellidos" => "Caminero" "email" => array:1 [ 0 => "jcamlun@gobiernodecanarias.org" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Joan A." "apellidos" => "Caylá" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 2 => array:3 [ "nombre" => "José-María" "apellidos" => "García-García" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 3 => array:3 [ "nombre" => "Francisco J." "apellidos" => "García-Pérez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 4 => array:3 [ "nombre" => "Juan J." "apellidos" => "Palacios" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] ] ] 5 => array:3 [ "nombre" => "Juan" "apellidos" => "Ruiz-Manzano" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">h</span>" "identificador" => "aff0040" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">i</span>" "identificador" => "aff0045" ] ] ] ] "afiliaciones" => array:9 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Hospital General de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Las Palmas, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Unidad de Tuberculosis con Multi-Drogo Resistencia, Unión Internacional contra la Tuberculosis y Enfermedades Respiratorias (La Unión), París, France" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Programa Integrado de Investigación en Tuberculosis (PII TB) de la Sociedad Española de Neumología y Cirugía Torácica SEPAR, Barcelona, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Epidemiologia, Agència de Salut Pública de Barcelona, CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Neumología, Hospital Universitario San Agustín, Avilés, Asturias, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario de La Princesa, Madrid, Spain" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Unidad de Referencia Regional de Micobacterias, Servicio de Microbiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "g" "identificador" => "aff0035" ] 7 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain" "etiqueta" => "h" "identificador" => "aff0040" ] 8 => array:3 [ "entidad" => "CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain" "etiqueta" => "i" "identificador" => "aff0045" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios a la normativa SEPAR de diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We are grateful to Dr. Pascual for his insightful comments<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> on our recently published guidelines on the diagnosis and treatment of drug-resistant tuberculosis (TB).<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> His letter addresses 2 points that we would like to discuss further.</p><p id="par0010" class="elsevierStylePara elsevierViewall">We fully agree with the first of his comments, regarding the good anti-<span class="elsevierStyleItalic">Mycobacterium tuberculosis</span> activity of bedaquiline and delamanid. As shown in Table 3 of our guidelines,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> the effectiveness of these new drugs prompted us to include them among the core drugs (our group 4) instead of among the add-on agents (Group D) recommended in the 2016 WHO recommendations<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a>; we agree that these 2 drugs should have been included in WHO group C.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> As early as 2015, our group published an article in the <span class="elsevierStyleItalic">European Respiratory Journal</span>, proposing that these new drugs (along with linezolid) should even be positioned above second-line injectable drugs.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">4</span></a> The reason for not including these drugs in treatment regimens from the outset is not so much financial, but because we feel that evidence for such use is still scant. The inclusion of these drugs in group 4 illustrates our view: they are very good but evidence is still lacking. However, by including them in group 4, we are providing the option for their use in MDR-TB regimens.</p><p id="par0015" class="elsevierStylePara elsevierViewall">As for shorter MDR-TB regimens, Dr. Pascual rightly points out that many issues remained unclear in the 2016 WHO publication.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> For this reason, and because of concerns surrounding the applicability of these regimens in practice, the WHO subsequently published an article which addressed many of these controversies.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> In it, they stated that the decision to use shorter regimens should not be based on sensitivity testing to the drugs in the regimen, other than fluoroquinolones or second-line injectables. This is because sensitivity results for these drugs, including pyrazinamide, are unreliable. The authors go so far as to say that even if resistance to pyrazinamide is observed, the clinician can consider using these shorter regimens.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> Furthermore, our recommendation not to use these regimens in pregnant women and in extrapulmonary TB is based on a lack of evidence, even though we are aware that they are used in these patient groups in some countries.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Caminero JA, Caylá JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Comentarios a la normativa SEPAR de diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos. Arch Bronconeumol. 2018;54:298.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comentarios al tratamiento de la tuberculosis con resistencia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.F. Pascual Pareja" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2018" "volumen" => "54" "paginaInicial" => "297" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnóstico y tratamiento de la tuberculosis con resistencia a fármacos" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J.A. Caminero" 1 => "J.A. Caylà" 2 => "J.M. García-García" 3 => "F.J. García-Pérez" 4 => "J.J. Palacios" 5 => "J. Ruiz Manzano" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2017.02.006" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "volumen" => "53" "paginaInicial" => "501" "paginaFinal" => "509" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28359606" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "WHO/HTM/TB/2016.04" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "WHO treatment guidelines for drug-resistant tuberculosis. 2016 update" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "World Health Organization" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:4 [ "fecha" => "2016" "paginaInicial" => "1" "paginaFinal" => "59" "editorial" => "World Health Organization Document" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Classification of antituberculosis drugs: a new proposal based on the most recent evidence" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.A. Caminero" 1 => "A. Scardigli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/13993003.00432-2015" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2015" "volumen" => "46" "paginaInicial" => "887" "paginaFinal" => "893" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26424519" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under programmatic conditions. Version: 20" "autores" => array:1 [ 0 => array:2 [ "colaboracion" => "World Health Organization" "etal" => false ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2016, December" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005400000005/v1_201804290447/S1579212918300892/v1_201804290447/en/main.assets" "Apartado" => array:4 [ "identificador" => "45358" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005400000005/v1_201804290447/S1579212918300892/v1_201804290447/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212918300892?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 2 | 6 |
2024 October | 31 | 11 | 42 |
2024 September | 37 | 18 | 55 |
2024 August | 60 | 34 | 94 |
2024 July | 47 | 24 | 71 |
2024 June | 52 | 20 | 72 |
2024 May | 73 | 26 | 99 |
2024 April | 34 | 25 | 59 |
2024 March | 45 | 22 | 67 |
2024 February | 43 | 19 | 62 |
2023 March | 13 | 5 | 18 |
2023 February | 25 | 24 | 49 |
2023 January | 21 | 30 | 51 |
2022 December | 51 | 36 | 87 |
2022 November | 42 | 24 | 66 |
2022 October | 61 | 58 | 119 |
2022 September | 37 | 34 | 71 |
2022 August | 33 | 48 | 81 |
2022 July | 32 | 47 | 79 |
2022 June | 31 | 42 | 73 |
2022 May | 34 | 48 | 82 |
2022 April | 28 | 40 | 68 |
2022 March | 39 | 60 | 99 |
2022 February | 37 | 23 | 60 |
2022 January | 31 | 42 | 73 |
2021 December | 43 | 44 | 87 |
2021 November | 29 | 47 | 76 |
2021 October | 37 | 58 | 95 |
2021 September | 35 | 42 | 77 |
2021 August | 22 | 45 | 67 |
2021 July | 28 | 26 | 54 |
2021 June | 52 | 43 | 95 |
2021 May | 40 | 50 | 90 |
2021 April | 81 | 101 | 182 |
2021 March | 48 | 31 | 79 |
2021 February | 33 | 20 | 53 |
2021 January | 43 | 20 | 63 |
2020 December | 35 | 19 | 54 |
2020 November | 16 | 21 | 37 |
2020 October | 33 | 22 | 55 |
2020 September | 33 | 17 | 50 |
2020 August | 29 | 18 | 47 |
2020 July | 29 | 28 | 57 |
2020 June | 19 | 8 | 27 |
2020 May | 49 | 16 | 65 |
2020 March | 15 | 10 | 25 |
2020 February | 98 | 23 | 121 |
2020 January | 32 | 17 | 49 |
2019 December | 21 | 13 | 34 |
2019 November | 26 | 19 | 45 |
2019 October | 23 | 12 | 35 |
2019 September | 22 | 13 | 35 |
2019 August | 38 | 21 | 59 |
2019 July | 25 | 17 | 42 |
2019 June | 25 | 15 | 40 |
2019 May | 26 | 29 | 55 |
2019 April | 30 | 40 | 70 |
2019 March | 45 | 24 | 69 |
2019 February | 34 | 18 | 52 |
2019 January | 57 | 24 | 81 |
2018 December | 51 | 22 | 73 |
2018 November | 56 | 29 | 85 |
2018 October | 9 | 0 | 9 |